Neurovalens
Neurovalens develops non-invasive neurostimulation medical devices designed to treat chronic health conditions such as insomnia, PTSD, and obesity. Its primary products, Modius Sleep and Modius Spero, utilize neuromodulation technology to deliver drug-free treatments that are FDA-authorized and physician-prescribed. The company targets patients seeking alternative therapies for mental health and metabolic issues, with a specific focus on providing solutions for veterans through the VA.
Visit websiteBelfast, United Kingdom
Healthtech
Medical Devices
Neurotechnology
Funding summary
- Total raised
- €21.6M
- Funding rounds
- 5
Investors in Neurovalens
Investors on record for Neurovalens. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Neurovalens?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors